MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pernix Therapeutics Holdings Company Profile (NYSE:PTX)

Consensus Ratings for Pernix Therapeutics Holdings (NYSE:PTX) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $6.62 (1,254.60% upside)

Analysts' Ratings History for Pernix Therapeutics Holdings (NYSE:PTX)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2016Brean CapitalReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016S&P Equity ResearchLower Price Target$1.37 -> $1.12View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016JMP SecuritiesLower Price TargetMarket Outperform$8.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Cantor FitzgeraldSet Price TargetHold$8.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2015Piper JaffrayInitiated CoverageOverweight$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Longbow ResearchDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2014Avondale PartnersInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2014Citigroup Inc.UpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2014AegisUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha